Search Results - "Vašáková, Martina Koziar"
-
1
Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone
Published in PloS one (01-09-2022)“…Background There is no clear evidence whether pirfenidone has a benefit in patients with probable or possible UIP, i.e. when idiopathic pulmonary fibrosis…”
Get full text
Journal Article -
2
Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortium
Published in Insights into imaging (22-10-2024)“…The Strengthening the Screening of Lung Cancer in Europe (SOLACE) initiative, supported by Europe’s Beating Cancer Plan, is dedicated to advancing lung cancer…”
Get full text
Journal Article -
3
The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry
Published in BMC pulmonary medicine (03-05-2023)“…The antifibrotic drug nintedanib is used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the effect of nintedanib on antifibrotic…”
Get full text
Journal Article -
4
Important steps towards a big change for lung health: a joint approach by the European Respiratory Society, the European Society of Radiology and their partners to facilitate implementation of the European Union's new recommendations on lung cancer screening
Published in ERJ open research (01-05-2023)“…https://bit.ly/3J4O0Jb…”
Get full text
Journal Article -
5
Short- and long-term clinical outcomes of nintedanib therapy in IPF patients with different phenotypes: A retrospective registry-based study
Published in Respiratory medicine (01-11-2024)“…There is a lack of data on the long-term effect of nintedanib on survival in specific groups of idiopathic pulmonary fibrosis (IPF) patients with different…”
Get full text
Journal Article -
6
The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry
Published in Archivos de bronconeumología (English ed.) (01-02-2024)“…[Display omitted] Most patients with idiopathic pulmonary fibrosis (IPF) treated with antifibrotics (AF) have progressive disease despite treatment. A switch…”
Get full text
Journal Article -
7
CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC)
Published in Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia (01-12-2023)“…Complex networks of chemokines are part of the immune reaction targeted against tumor cells. Chemokines influence cancer growth. It is unclear whether the…”
Get full text
Journal Article -
8
Adherence to the ISHLT Protocol for the Referral of Patients with Idiopathic Pulmonary Fibrosis to the Transplantation Center among of Czech Centers for Interstitial Lung Diseases
Published in Pulmonary medicine (30-06-2024)“…There are limited data on referral rates and the number of patients with idiopathic pulmonary fibrosis (IPF) who are eligible for lung transplantation. The aim…”
Get full text
Journal Article -
9
Reply to Dutkiewicz and Mackiewicz
Published in American journal of respiratory and critical care medicine (15-07-2023)Get full text
Journal Article -
10
Flow cytometry-based method using diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease
Published in Tuberculosis (Edinburgh, Scotland) (01-07-2024)“…Authors present a pilot study of the development of innovative flow cytometry-based assay with a potential for use in tuberculosis diagnostics. Currently…”
Get full text
Journal Article -
11
Biodegradable tracheal stents: our ten-year experience with adult patients
Published in BMC pulmonary medicine (15-05-2024)“…Biodegradable (BD) stents made from polydioxanone have been used only in human airways. These stents combine the advantages of classical tracheal stents, and…”
Get full text
Journal Article -
12
Hypersensitivity Pneumonitis: Correct Identification of Causative Microbial Agents Is Essential for Efficient Diagnosis and Prevention/Reply
Published in American journal of respiratory and critical care medicine (15-07-2023)“…Raghu et al explain that hypersensitivity pneumonitis (HP) is an immune-mediated disease triggered by organic and nonorganic materials (inducers) in…”
Get full text
Journal Article -
13
Eosinophils—from cradle to grave
Published in Allergy (Copenhagen) (01-12-2023)“…Over the past years, eosinophils have become a focus of scientific interest, especially in the context of their recently uncovered functions (e.g. antiviral,…”
Get full text
Journal Article -
14
Pathologic Criteria for the Diagnosis of Usual Interstitial Pneumonia vs Fibrotic Hypersensitivity Pneumonitis in Transbronchial Cryobiopsies
Published in Modern pathology (01-09-2023)“…Transbronchial cryobiopsy (TBCB) is increasingly used for the diagnosis of fibrosing interstitial pneumonias, but there are few detailed descriptions of the…”
Get full text
Journal Article -
15
Pathological features of connective tissue disease-associated interstitial lung disease in transbronchial cryobiopsies
Published in Histopathology (02-09-2024)“…Transbronchial cryobiopsies are increasingly used for the diagnosis of interstitial lung disease (ILD), but there is a lack of published information on the…”
Get full text
Journal Article -
16
Eosinophils-from cradle to grave: An EAACI task force paper on new molecular insights and clinical functions of eosinophils and the clinical effects of targeted eosinophil depletion
Published in Allergy (Copenhagen) (01-12-2023)“…Over the past years, eosinophils have become a focus of scientific interest, especially in the context of their recently uncovered functions (e.g. antiviral,…”
Get full text
Journal Article -
17
EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients
Published in Respiratory medicine (01-11-2023)“…•Manuscript: YRMED-D-23-00719.•Highlights are optional yet highly encouraged for this journal, as they increase the discoverability of your article via search…”
Get full text
Journal Article